🇺🇸 FDA
Patent

US 8642741

Human antibodies to human TNF-like ligand 1A (TL1A)

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 8642741 (Human antibodies to human TNF-like ligand 1A (TL1A)) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K39/39558, A61K45/06